WEDNESDAY, Dec. 6, 2023 (HealthDay News) — The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. “Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound,” Rhonda Pacheco,Continue Reading
WEDNESDAY, Dec. 6, 2023 (HealthDay News) — In sickness and in health — and in blood pressure, too? A new international study finds that if your blood pressure rises with time, your spouse’s might, also. “Many people know that high blood pressure is common in middle-aged and older adults, yetContinue Reading
MONDAY, Dec. 4, 2023 (HealthDay News) — Holiday festivities bring joy to many, but they also give rise to quite a few unhealthy habits, a new survey has found. Two-thirds of people say they overindulge in food during the holidays, and nearly half (45%) said they take a break fromContinue Reading
FRIDAY, Dec. 1, 2023 (HealthDay News) — A new study of identical twins has provided fresh evidence that a vegan diet can vastly improve a person’s heart health. Twins assigned a vegan diet for two months had significant improvements in cholesterol, insulin and body weight compared to their siblings, whoContinue Reading
WEDNESDAY, Nov. 29, 2023 (HealthDay News) — Dreary, chilly winter days might cause some year-round runners to think twice about their jog, but recent research suggests the benefits of cold weather running outweigh those of running in warmer conditions. Specifically, cold weather can help runners burn more bad fat, loseContinue Reading
WEDNESDAY, Nov. 29, 2023 (Healthday News) — The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetiteContinue Reading
MONDAY, Nov. 20, 2023 (HealthDay News) — Middle-aged folks with lots of belly fat surrounding their internal organs appear to be at higher risk for Alzheimer’s disease later in life, a new study suggests. This hidden abdominal fat — known as visceral fat — is related to changes in theContinue Reading
WEDNESDAY, Nov. 15, 2023 (HealthDay News) — Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows. A wider study, published in June, found that retatrutide helped obese people lose about a quarter of theirContinue Reading
MONDAY, Nov. 13, 2023 (Healthday News) — In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%. The results from this large, internationalContinue Reading
FRIDAY, Nov. 10, 2023 (HealthDay News) — Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study, scientists found excessive insulin levels overstimulated pancreatic acinar cells, which produce digestiveContinue Reading